Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells

Drug Metabolism and Disposition

Volumn 39, Issue 3, 2011, Pages 456-464

  Zhang, Hongbo ^a   Tolonen, Ari ^b   Rousu, Timo ^b   Hirvonen, Jouni ^a   Finel, Moshe ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Novamass Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHOL; ALAMETHICIN; DICLOFENAC; DIMETHYL SULFOXIDE; EPITESTOSTERONE; ETHINYLESTRADIOL; GLUCURONOSYLTRANSFERASE; INDOMETACIN; OXAZEPAM; PROPOFOL; PROPRANOLOL; TRIFLUOPERAZINE; ZIDOVUDINE;

ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL STRAIN CACO 2; DRUG GLUCURONIDATION; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE MICROSOME; LIPOPHILICITY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY; MICROSOME; PRIORITY JOURNAL;

ALAMETHICIN; CACO-2 CELLS; CELL DIFFERENTIATION; DIMETHYL SULFOXIDE; ENTEROCYTES; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; INTESTINE, SMALL; IONOPHORES; ISOENZYMES; MICROSOMES; MICROSOMES, LIVER; PHARMACEUTICAL PREPARATIONS; RECOMBINANT PROTEINS; SOLUBILITY; SOLVENTS;

EID: 79951921433     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.036582     Document Type: Article

References (33)

1. Abid A, Bouchon I, Siest G, and Sabolovic N (1995) Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransferase 1*6. Biochem Pharmacol 50: 557-561.
2. Court MH (2005) Isoform-selective probe substrates for in vitro studies of human UDPglucuronosyltransferases. Methods Enzymol 400:104-116.
3. Court MH, Duan SX, Guillemette C, Journault K, Krishnaswamy S, Von Moltke LL, and Greenblatt DJ (2002) Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab Dispos 30:1257-1265. (Pubitemid 35265834)
4. Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, and Greenblatt DJ (2003) Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31:1125-1133. (Pubitemid 37048284)
5. Fisher MB, Campanale K, Ackermann BL, VandenBranden M, and Wrighton SA (2000) In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560-566. (Pubitemid 30238515)
6. Hidalgo IJ, Raub TJ, and Borchardt RT (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749. (Pubitemid 19057595)
7. Itäaho K, Court MH, Uutela P, Kostiainen R, Radominska-Pandya A, and Finel M (2009) Dopamine is a low-affinity and high-specificity substrate for the human UDPglucuronosyltransferase 1A10. Drug Metab Dispos 37:768-775.
8. Itäaho K, Mackenzie PI, Ikushiro S, Miners JO, and Finel M (2008) The configuration of the 17-hydroxy group variably influences the glucuronidation of β-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos 36:2307-2315.
9. Kaivosaari S, Toivonen P, Aitio O, Sipilä J, Koskinen M, Salonen JS, and Finel M (2008) Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos 36:1529-1537.
10. Kaivosaari S, Toivonen P, Hesse LM, Koskinen M, Court MH, and Finel M (2007) Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. Mol Pharmacol 72:761-768. (Pubitemid 47347311)
11. Korjamo T, Mönkkönen J, Uusitalo J, Turpeinen M, Pelkonen O, and Honkakoski P (2006) Metabolic and efflux properties of Caco-2 cells stably transfected with nuclear receptors. Pharm Res 23:1991-2001.
12. Kurkela M, García-Horsman JA, Luukkanen L, Mörsky S, Taskinen J, Baumann M, Kostiainen R, Hirvonen J, and Finel M (2003) Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278:3536-3544. (Pubitemid 36801076)
13. Kurkela M, Patana AS, Mackenzie PI, Court MH, Tate CG, Hirvonen J, Goldman A, and Finel M (2007) Interactions with other human UDP- glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6. Pharmacogenet Genomics 17:115-126.
14. Kuuranne T, Kurkela M, Thevis M, Schänzer W, Finel M, and Kostiainen R (2003) Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31:1117-1124. (Pubitemid 37048283)
15. Köhle C, Badary OA, Nill K, Bock-Hennig BS, and Bock KW (2005) Serotonin glucuronidation by Ah receptor- and oxidative stress-inducible human UDP-glucuronosyltransferase (UGT) 1A6 in Caco-2 cells. Biochem Pharmacol 69:1397-1402.
16. Luukkanen L, Taskinen J, Kurkela M, Kostiainen R, Hirvonen J, and Finel M (2005) Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 33:1017-1026. (Pubitemid 41002784)
17. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685. (Pubitemid 41345319)
18. Meinl W, Ebert B, Glatt H, and Lampen A (2008) Sulfotransferase forms expressed in human intestinal Caco-2 and TC7 cells at varying stages of differentiation and role in benzo[a]pyrene metabolism. Drug Metab Dispos 36:276-283. (Pubitemid 351185739)
19. Ohno S and Nakajin S (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32-40.
20. Peters WH and Roelofs HM (1989) Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem J 264:613-616. (Pubitemid 20024537)
21. Pinto M, Robine-Leon S, Appay M, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simon- Assmann P, Haffen K, Fogh J, et al. (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47:323-330. (Pubitemid 14236699)
22. Press B and Di Grandi D (2008) Permeability for intestinal absorption: Caco-2 assay and related issues. Curr Drug Metab 9:893-900.
23. Prueksaritanont T, Gorham LM, Hochman JH, Tran LO, and Vyas KP (1996) Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab Dispos 24:634-642. (Pubitemid 26170714)
24. Sabolovic N, Humbert AC, Radominska-Pandya A, and Magdalou J (2006) Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells. Biopharm Drug Dispos 27:181-189. (Pubitemid 43797114)
25. Scharmach E, Hessel S, Niemann B, and Lampen A (2009) Glutathione S-transferase expression and isoenzyme composition during cell differentiation of Caco-2 cells. Toxicology 265:122-126.
26. Siissalo S, Laitinen L, Koljonen M, Vellonen KS, Kortejärvi H, Urtti A, Hirvonen J, and Kaukonen AM (2007) Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines. Eur J Pharm Biopharm 67:548-554. (Pubitemid 47211922)
27. Siissalo S, Zhang H, Stilgenbauer E, Kaukonen AM, Hirvonen J, and Finel M (2008) The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells. Drug Metab Dispos 36:2331-2336.
28. Sneitz N, Court MH, Zhang X, Laajanen K, Yee KK, Dalton P, Ding X, Finel M (2009) Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A. Pharmacogenet Genomics 19:923-934.
29. Soars MG, Ring BJ, and Wrighton SA (2003) The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases. Drug Metab Dispos 31:762-767. (Pubitemid 36617665)
30. Sten T, Bichlmaier I, Kuuranne T, Leinonen A, Yli-Kauhaluoma J, and Finel M (2009) UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. Drug Metab Dispos 37:417-423.
31. Uchaipichat V, Mackenzie PI, Elliot DJ, and Miners JO (2006) Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human UDP-glucuronosyltransferases. Drug Metab Dispos 34:449-456.
32. Uchaipichat V, Mackenzie PI, Guo XH, Gardner-Stephen D, Galetin A, Houston JB, and Miners JO (2004) Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 32:413-423. (Pubitemid 38420275)
33. Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, et al. (2004) Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281-290. (Pubitemid 38263885)